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http://www.biomedcentral.com/1472-6882/13/274RESEARCH ARTICLE Open AccessAttenuating effect of standardized fruit extract of
punica granatum L in rat model of tibial and sural
nerve transection induced neuropathic pain
Vivek Jain1, Ashutosh Pareek1, Yashumati Ratan Bhardwaj1 and Nirmal Singh2*Abstract
Background: Injury to a nerve is the most common reason of acquired peripheral neuropathy. Therefore, searching
for effective substance to recover of nerve after injury is need of present era. The current study investigates the
protective potential of Standardized Fruit Extract of Punica granatum L (PFE) [Ellagic acid (41.6%), Punicalagins
(10%), Granatin (5.1%)] in Tibial & Sural Nerve Transection (TST) induced neuropathic pain in rats.
Methods: TST was performed by sectioning tibial and sural nerve portions of the sciatic nerve and leaving the
common peroneal nerve intact. Acetone drop, pin-prick, hot plate, paint brush & Walking Track tests were performed
to assess cold allodynia; mechanical heat, hyperalgesia and dynamic mechanical allodynia & tibial functional index
respectively. The levels of TNF-α, TBARS, GSH and Nitrite were measured in the sciatic nerve as an index of
inflammation & oxidative stress.
Results: TST led to significant development of cold allodynia; mechanical and heat hyperalgesia; dynamic mechanical
allodynia; functional deficit in walking along with rise in the levels of TBARS, TNF-α, GSH and Nitrite. Administrations of
PFE (100 & 300 mg/kg oral), significantly attenuate TST induced behavioral & biochemical changes. Pretreatments of
BADGE (120 mg/kg IP) a PPAR-γ antagonist and nitric oxide precursor L-arginine (100 mg/kg IP) abolished the
protective effect of PFE. Whereas, pretreatment of L-NAME (5 mg/kg IP) a NOS inhibitor significantly potentiated PFE’s
protective effect of PFE.
Conclusion: PFE shown to have attenuating effect in TST induced neuropathic pain which may be attributed to
potential PPAR-gamma agonistic activity, nitric oxide inhibitory, anti-inflammatory and anti oxidative actions.
Keywords: Punica granatum L, Neuropathic pain, TNF-alpha, BADGE, Oxidative stressBackground
According to International Association for the Study of
Pain (IASP) Neuropathic pain (NP) is a pain arising as a
direct consequence of a lesion or disease affecting the
somatosensory system [1]. The prevalence of neuropathic
pain is projected at around 10% in the adult population
of the US, and is expected to be the similar in other
developed countries along with that its prevalence is
likely to increase 17% by 2020 countries [2]. NP can
crop up from damage to the nerve pathways at any
point from cortical neurons in the brain to the* Correspondence: nirmal_puru@rediffmail.com
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reproduction in any medium, provided the orterminals of the peripheral nociceptors and symptoms
may persist even after the treatment of initial injury [3].
Despite recent advances in the identification of NP the
pharmacologic management (Antidepressant, antiepileptics,
classical analgesics) of NP remains challenging and yet
costly to manage [4]. Therefore, there is a need for new
therapies that provide more predictable efficacy in all
patients with improved tolerability and it is also important
for the clinician to know which drugs are most effective
in relieving pain and associated with the fewest adverse
effects.
In recent years search shifted towards the substances
of natural origin which are prolific source of new drug
entity [5]. Punica granatum L, commonly known as
pomegranate; an ancient, spiritual, and oldest distinctive. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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is grown in South East Asia, the Mediterranean, the
Americas and other parts of the world including India. It
is used traditionally as both food and medicine {astringent
agent [6] for eradicating parasites [7] along with antipyr-
etic and analgesic in Chinese therapy [8]}. Several tannins,
flavonoids, anthocyanidins with various pharmacological
and biological activities viz. anti-oxidation [9], anti in-
flammatory [8], anti diarrhoea, anti-tumour [10], anti-
hepatotoxicity [11], anthelmintic, anti-lipoperoxidation
[12], anti ulcer [13], anti-bacterial [14], anti viral [15]
have been identified in pomegranate. In our own study,
hydroalcoholic extract and extract with ellagic acid
rich fraction of Punica granatum L was documented
to attenuate glycerol-induced acute renal failure in
rats and dextran sulfate sodium-induced ulcerative
colitis respectively [16,17].
Regardless of our present knowledge involving mo-
lecular and cellular pathways involved in injury induced
neuropathic pain, complete therapeutic prevention or
reversal of acute or chronic neuronal injury remains
intangible.
However, its potential in neuropathic pain remains to
be explored. Therefore, the present study was designed to
investigate the ameliorative potential of Punica granatum
L in Tibial and Sural nerve transaction induced neuro-
pathic pain in rats.
Methods
Experimental animals
Wistar rats of either sex, weighing 200–250 g (procured
from NIPER, Mohali) were employed in present study.
They were housed in animal cages with free access to
water and standard laboratory pellet chow diet (Hindustan
Liver Limited, India). The animals with cages were kept in
the departmental animal house (Temperature maintained
at 18 to 23°C; Humidity maintained at 30 to 35%) and
were exposed to normal cycle of light and dark. The
experimental protocol was approved by the Banasthali
University Institutional Animal Ethics Committee (BUIAEC)
and the care of the animals was carried out as per the
guidelines of the Committee for the Purpose of Control
and Supervision of Experiments on Animals (CPCSEA)
(Registration no. 574/02/ab/CPCSEA), Ministry of Envir-
onment and Forest, Government of India. After 1 week of
acclimatization, rats were used for experimental purpose.
Drugs and chemicals
Biphenol-A-diglicydyl ether (BADGE) & Gabapentin was
purchased from Cayman chemicals. Pomegranate fruit
extract (PFE) (Natural Remedies, Bangalore),1,1,3,3 tetra
methoxy propane (Sigma Aldrich, USA), DTNB [5,5’-dithio,
bis (2-nitro benzoic acid)], BSA (Bovine Serum Albumin)
(Sisco Research Laboratories Pvt. Ltd., Mumbai, India),Thio-barbituric acid, L-Arginine (HIMEDIA,India),
L-NAME, Folin-Ciocalteu’s phenol reagent (Merck Ltd.
Mumbai, India) were procured for the present study.
All the reagents used in the present study were of
analytical grade.
Procurement of pomegranate fruit extract (PFE)
Standardized pomegranate fruit extract [Ellagic acid
(41.6%), Punicalagins (10%), Granatin (5.1%), heavy metal
(Not More Than 10 PPM)] was generous gift from Natural
Remedies, Bangalore, INDIA. It was stored in airtight
container at low temperature (below 25°C) and suspended
in 0.5% carboxy methylcellulose (CMC) before oral
administration.
Induction of neuropathic pain by tibial and sural nerve
transection
Peripheral neuropathic pain was induced by tibial and
sural nerve transection as described by Dowdall, 2005 [18].
In brief, the rat was deeply anesthetized with ketamine
(60 mg/kg IP). The skin of its lateral surface of the left
thigh was incised and a cut made directly through the
biceps femoris muscle to expose the sciatic nerve and its
three terminal branches (the sural, common peroneal
and tibial nerves). Thereafter, the tibial and sural nerve
sections of 2 mm (distal to the trifurcation) were ligated
and cut. The common peroneal nerve was left intact and
no contact was made with it. The muscle and the skin
were closed in two layers. Sham controls were performed
by exposing the sciatic nerve and its branches without
inducing any lesion. All the surgical procedures were
carried out under normal sterile conditions and were
performed by the same experimenter.
Behavioural examination
Cold-allodynia (acetone drop test)
The cold allodynia was assessed by spraying a 100 μL of
acetone onto the surface of the paw, without touching
the skin. The response of the rat to acetone was noted
for 20 s and was graded to a 4-point scale as defined by
Flatters and Bennett [19]. 0, no response; 1, quick with-
drawal, flick or stamp of the paw; 2, prolonged withdrawal
or repeated flicking; 3, repeated flicking of the paw with
licking of the paw. Acetone was applied thrice to the hind
paw, with a gap of 5 min between the acetone applications
and the individual scores noted in 20 second interval were
added to obtain a single score over a cumulative period
of 60 s. The minimum score was 0, while the maximum
possible score was 9.
Mechanical hyperalgesia (pin-prick test)
The mechanical hyperalgesia was assessed by the pin-
prick test as described by Erichsen and Blackburn-Munro
[20]. The surface of the injured hind paw was touched
   
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syringe) at intensity sufficient to produce a reflex with-
drawal response. The duration of the paw withdrawal was
recorded in sec.Heat-hyperalgesia (hot plate test)
The thermal nociceptive threshold, as an index of thermal
hyperalgesia, was assessed by the hot plate, maintained at
a temperature of 52.5 ± 1.0°C. The rat was placed on the
hot plate and nociceptive threshold, with respect to licking
of the hind paw, was recorded in s. The cut-off time of
15 sec was maintained [21].Mechanical dynamic allodynia (paint-brush test)
The “paint-brush” behavioural test has been used to
explore dynamic responses to a mechanical stimulus. The
response to smooth paint-brush has been described as
allodynia because normal rats never withdraw from this
stimulus. It has been established that dynamic mechanical
allodynia is mediated by peripheral low threshold, large
myelinated Aβ-fibers [22]. The rat was placed in the cylin-
der with the wire mesh floor and a smooth paint-brush
was used to rub the plantar area of hind paw from the heel
to the toes as a stimulus. The stimulus was applied five
times with a 5 sec interval and the number of withdrawals
was noted (between 0 and 5). The same procedure was
repeated twice, with a gap of five min and the total
number of withdrawals (in three tests) was added to
obtain a single cumulative score of mechanical dynamic
allodynia with a minimum value of 0 and maximum of
15 [23].Cold-hyperalgesia test (tail immersion test)
Tail cold-hyperalgesia was noted by immersing a terminal
part of the tail (1 cm) in the water, maintained at a
temperature of 0–4°C. The tail withdrawal latency was
recorded and a cut-off time of 20 s was maintained [24].Walking track test (De medinacelli method)
Rats were allowed conditioning trials in a walking track
(8.2 × 42 cm) darkened at one end. White paper cut to
the appropriate dimensions was placed on the bottom of
the track. The rat’s hind limbs were dipped in ink, and
the rat was permitted to walk down the track, leaving its
hind foot prints on the paper [25]. Foot prints were
obtained on day 1, 12, and 24 after surgery.
From the footprints, several measurements were
undertaken and the so called Tibial Function Index
(TFI) was calculated by the equation. TFI of zero de-
fines normal function of the tibial nerve, while a TFI
of −100% is presumed to represent complete func-








Print Length (PL) - Distance from the heel to the top
of the third toe; Toe Spread (TS) - distance between the
first and the fifth toe and Intermediary Toe Spread (IT)
represents distance from the second to the fourth toe.
These measures were taken both from the non-operated
foot [NPL(Non-operated foot Print Length), NTS
(Non-operated foot Toe Spread), NIT(Non-operated
foot Intermediary Toe Spread)] and from the operated,
experimental foot [EPL(Experimental foot Print Length),
ETS(Experimental foot Toe Spread) and EIT(Experimental
foot Intermediary Toe Spread)].
Biochemical estimations
The animals were sacrificed after 24th day by high dose
anesthesia and the portions of the sciatic nerve and the
tissue beneath the sciatic nerve were isolated immedi-
ately. The sciatic nerve portion, proximal to the point of
transection up to its point of emergence from the spinal
cord, and distal to the point of transection up to its ending,
was excised. The sciatic nerve homogenate (10%, w/v) was
prepared with 0.1 M Tris–HCl buffers (pH 7.4). The tubes
with homogenate were kept in the ice water for 30 min
and centrifuged at 4°C (2000 × g, 10 min). The supernatant
of the homogenate was separated and employed to esti-
mate the total protein content and the thio-barbituric acid
reactive substances.
Estimation of protein content
The protein concentration in the sciatic nerve was esti-
mated according to the method of Lowry et al. [26] using
bovine serum albumin as a standard.
Estimation of thio-barbituric acid reactive substances
(TBARS)
The estimation of lipid peroxidation was done by meas-
uring the TBARS as described by Okhawa et al. [27].
The absorbance was measured spectrophotometrically at
532 nm. The concentration was expressed in terms of
nmol of TBARS/mg of the protein.
Estimation of reduced glutathione levels
The reduced glutathione levels were measured according
to the method of Beutler et al. [28]. The equal quantity
of the sciatic nerve homogenate was mixed with tri-
chloroacetic acid (10%) and centrifuged to separate the
proteins. To 0.01 mL of this supernatant, 2 mL of phos-
phate buffer (pH 8.4), 0.5 mL of DTNB (5, 5-dithio, bis
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water was added. The mixture was vortexed and the
absorbance was taken at 412 nm within 15 min. The
concentration of the reduced glutathione was expressed
as μg/mg of the protein.
Estimation of nitrite
Accumulation of nitrite was measured in cell free su-
pernatants by spectrophotometer assay based on Greiss
reagent (1% sulphanilamide/0.1% naphthylethylenediamine
dihydrochloride/2.5% phosphoric acid) and incubated
at room temperature for 10 min to yield a chromophore.
Absorbance was read at 543 nm spectrophotometrically.
The nitrite concentration was calculated from a standard
curve using sodium nitrite as standard and expressed as
micro molar nitrite per milliliter homogenate [29].
Estimation of TNF-α
The sciatic nerve was homogenized in phosphate buffered
saline, pH 7.4, and the homogenates were centrifuged at
1500 g, at 4°C for 10 min and the supernatant was imme-
diately used for the TNF-α with commercially available
enzyme-linked immunosorbent assay (ELISA). The concen-
tration of TNF-α was expressed in pg/mg of protein [3].
Experimental protocol
Eighteen groups, each group comprising six Wistar albino
rats, were employed in the present study. Behavioral
tests were assessed on 1st, 12th and 24th day. AnimalTable 1 Experimental groups of animals and substances adm
Groups n Substance Description
I 6 Normal control Only fodder and water.
II 6 Sham control Tibial and Sural nerve expos
III 6 TST TST were performed.
IV 6 Vehicle in TST CMC 0.5% w/v, p. o. was ad
V 6 PFE per se PFE (300 mg/kg p. o. ones d
VI&VII 6 PFE + TST PFE (100 and 300 mg/kg p.
days
VIII 6 BADGE (PPAR-γ antagonist) +
TST
BADGE was administered (1
IX & X 6 BADGE + PFE + TST BADGE was administered (1
administration to the TST ra
XI 6 L-NAME + TST L-NAME was administered (5
XII 6 L-arginine + TST L-arginine was administered
XIII &
XIV
6 L-NAME + PFE + TST L-NAME was administered (5
administration to the TST ra
XV & XVI 6 L-arginine + PFE + TST L-arginine was administered
administration to the TST ra
XVII 6 Gabapentin per se Gabapentin (100 mg/kg) p.
XVIII 6 Gabapentin + TST Gabapentin (100 mg/kg) p.
TST- Tibial and Sural Nerve Transection; CMC – carboxymethylcellulose; PFE - Punica
IP- Intraperitoneal.were sacrificed on 24th day & the biochemical estimations
were done as described earlier. Dose of PFE was selected
according to Waghulde et al. [30]. Whole experimental
protocol has been shown in Table 1.
Statistical analysis
All the results were expressed as mean ± standard error
of means (S.E.M.). The data from the behavioral and bio-
chemical results were statistically analyzed by two-way
analysis of variance followed by Bonferonni’s post-test
and one-way ANOVA followed by Tukey’s multiple range
tests, respectively by using Graph pad prism Version-5.0
software. The P-value <0.05 was considered to be statisti-
cally significant.
Result
Administration of PFE (300 mg/kg p. o.) and GABAPEN-
TIN (100 mg/kg p. o.) along with vehicle (carboxymeth-
ylcellulose) did not modulate behavioural functions in
normal rats.
Effect of various interventions on tibial and sural nerve
transaction (TST)-induced hyperalgesia, allodynia and
functional deficit
TST resulted in significant development of mechanical
hyperalgesia (Figure 1); cold hyperalgesia (Figure 2), heat
hyperalgesia (Figure 3), cold allodynia (Figure 4), mech-
anical dynamic allodynia (Figure 5) and functional deficit
[in terms of Tibial Functional Index (TFI) {Table 2}] asinistered
ed without any transaction.
ministered for 24 days daily.
aily) was administered to the normal rats for 24 consecutive days.
o. respectively) were administered to the TST rats for 24 consecutive
20 mg/kg IP) to the TST rats for 24 consecutive days.
20 mg/kg IP) before PFE (100 and 300 mg/kg p. o. respectively)
ts for 24 consecutive days.
mg/kg IP) to the TST rats for 24 consecutive days.
(100 mg/kg IP) to the TST rats for 24 consecutive days.
mg/kg IP) before PFE (100 and 300 mg/kg p. o. respectively)
ts for 24 consecutive days.
(100 mg/kg IP) before PFE (100 and 300 mg/kg p. o. respectively)
ts for 24 consecutive days.
o. administration to the normal rats for 24 consecutive days.
o. administration to the TST rats for 24 consecutive days.
granatum L Fruit Extract; BADGE- Biphenol-A-diglicydyl ether; p. o.- per os;
Figure 1 Effect of PFE on mechanical hyperalgesia, assessed by the pinprick test, in Tibial and Sural nerve Transection (TST)-induced
neuropathic pain. Values are mean ± S.E.M. n = 6 rats per group. a = P < 0.05 vs. sham control group. b = P < 0.05 vs. TST group. c = P < 0.05 vs.
PFE 100 + TST. d = P < 0.05 vs. PFE 300 + TST. e = P < 0.05 vs. L-NAME + PFE (300 mg/kg) + TST.
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prick, tail immersion test, hot plate tests, acetone drop,
paint brush test and walking track test respectively. Ad-
ministration of PFE (100 & 300 mg/kg, p. o.) & gabapentin
(100 mg/kg p. o.) for 24 days attenuated TST -induced
hyperalgesia [Cold hyperalgesia {F (22,180) = 18.41};
Heat hyperalgesia {F (22,180) = 52.65}; Mechanical hyper-
algesia {F (22,180) = 45.08}], allodynia [Cold allody-
nia {F (22,180) = 38.40}; Mechanical dynamic allodynia
{F (22,180) = 111.40}] and tibial functional deficit (TFI)
[F (22,180) = 51.94] in a significant manner. Further, pre-
treatment of L-NAME (5 mg/kg IP) significantly potenti-
ated antihyperalgesic, antiallodynic effect and functional
recovery (TFI) of PFE as compared to TST group. InFigure 2 Effect of PFE on cold hyperalgesia, assessed by the tail imm
neuropathic pain. Values are mean ± S.E.M. n = 6 rats per group. a = P < 0
PFE 100 + TST. d = P < 0.05 vs. PFE 300 + TST. e = P < 0.05 vs. L-NAME + PFaddition, pretreatments of L-arginine (100 mg/kg IP) and
BADGE (120 mg/kg IP) abolished the effect of PFE (100 &
300 mg/kg p.o.) on TST-induced hyperalgesia, allodynia
and functional recovery (TFI).
Effect of various interventions on TBARS levels
TST resulted in a significant increase in the levels of
thio-barbituric acid reactive substances as compared to
sham control (Table 3). Administration of PFE (both doses)
for 24 days attenuated TST induces increase in the levels
of thio-barbituric acid reactive substances in significant
manner [with F (15, 80) =62.10]. Further, L-NAME also
attenuated TST induced rise in the levels of TBARS,
whereas L-arginine augmented TST induce increase in theersion test, in Tibial and Sural nerve Transection (TST)-induced
.05 vs. sham control group. b = P < 0.05 vs. TST group. c = P < 0.05 vs.
E (300 mg/kg) + TST.
Figure 3 Effect of PFE on heat hyperalgesia assessed by the hot plate test, in Tibial and Sural nerve Transection (TST)-induced
neuropathic pain. Values are mean ± S.E.M. n = 6 rats per group. a = P < 0.05 vs. sham control group. b = P < 0.05 vs. TST group. c = P < 0.05 vs.
PFE 100 + TST. d = P < 0.05 vs. PFE 300 + TST. e = P < 0.05 vs. L-NAME + PFE (300 mg/kg) + TST.
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& BADGE did not modulate TBARS level in TST induced
neuropathic pain.
Effect of various interventions on reduced
glutathione levels
TST resulted in a significant decrease in the levels of
reduced glutathione as compared to sham control (Table 3).
Administration of PFE (both doses) for 24 days attenuated
TST induces decrease in the levels of reduced glutathione
in significant manner [with F (15, 80) =14.07]. Further,
L-NAME also attenuated TST induce decrease in the
levels of reduced glutathione; whereas L-arginine aug-
mented TST induce decrease in the levels of reducedFigure 4 Effect of PFE on cold Allodynia assessed by the acetone test
pain. Values are mean ± S.E.M. n = 6 rats per group. a = P < 0.05 vs. sham
TST. d = P < 0.05 vs. PFE 300 + TST. e = P < 0.05 vs. L-NAME + PFE (300 mgglutathione. However, administration of gabapentin &
BADGE did not modulate reduced glutathione level in
TST induced neuropathic pain.Effect of various interventions on nitrite level
TST resulted in a significant increase in the levels of Nitrite
as compared to sham control (Table 3). Administration of
PFE, L-NAME and gabapentin for 24 days attenuated TST
induce increase in the levels of Nitrite in significant manner
[with F (15, 80) =8.36]. Further, L-arginine augmented TST
induce increase in the levels of Nitrite. However, adminis-
tration of BADGE did not modulate Nitrite level in TST
induced neuropathic pain., in Tibial and Sural nerve Transection (TST)-induced neuropathic
control group. b = P < 0.05 vs. TST group. c = P < 0.05 vs. PFE 100 +
/kg) + TST.
Figure 5 Effect of PFE on mechanical dynamic Allodynia assessed by the paint brush test, in Tibial and Sural nerve Transection
(TST)-induced neuropathic pain. Values are mean ± S.E.M. n = 6 rats per group. a= P < 0.05 vs. sham control group. b = P < 0.05 vs. TST group.
c = P < 0.05 vs. PFE 100 + TST. d = P < 0.05 vs. PFE 300 + TST. e = P < 0.05 vs. L-NAME + PFE (300 mg/kg) + TST.
Table 2 TFI (Walking Track Test): tibial functional index in
terms of % functional deficit of nerve in different groups
Group name Day 1 Day 12 Day 24
Normal control −10.23 −7.24 −11.57
Sham control −11.54 −6.52 −12.56
Vehicle in TST −66.15a −88.63a −87.22a
TST −67.45a −93.34a −89.45a
PFE 300 mg/kg per se −10.45 −8.12 −12.15
GABAPENTIN100mg/kg per se −11.95 −13.59 −13.78
PFE 100 mg/kg + TST −58.34b −48.23b −41.16b
PFE 300 mg/kg + TST −54.53b −24.33b −18.54b
BADGE + PFE 100 mg/kg + TST −62.32c −64.22c −67.59c
BADGE + PFE 300 mg/kg + TST −61.13d −58.43d −54.22d
BADGE + TST −69.44a −95.24 a −90.03a
L-NAME + TST −60.71b −36.25b −31.33b
L-arginine + TST −68.33a −92.28a −88.44a
L-NAME + PFE 100 mg/kg + TST −55.32b −41.79b −37.66b
L-NAME + PFE 300 mg/kg + TST −50.58b −18.56b −15.46b
L-arginine + PFE 100 mg/kg + TST −62.21a −56.42a −49.13a
L-arginine + PFE 300 mg/kg + TST −58.88e −44.78e −41.36e
GABAPENTIN 100 mg/kg + TST −52.21b −20.02b −15.43b
a = P < 0.05 vs. sham control group.
b = P < 0.05 vs. TST group.
c = P < 0.05 vs. PFE 100 + TST.
d = P < 0.05 vs. PFE 300 + TST.
e = P < 0.05 vs. L-NAME + PFE (300 mg/kg) + TST.
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TST resulted in a significant increase in the levels TNF –α
as compared to sham control (Table 3). Administration
of PFE for 24 days attenuated TST induces increase
in the levels TNF –α in a significant manner [with F
(15, 80) =130.0]. However, administration of gabapentin
L-NAME, L-arginine & BADGE did not modulate
TNF –α level in TST induced neuropathic pain.Discussion
Several studies demonstrated that various transaction,
ligation, and crushing of sciatic nerve and its branches
induces an ipsilateral mechanical, cold, heat hyperalgesia
and allodynia thereby indicating the induction of peripheral
neuropathic pain [3,31]. These behavioral alterations are
constantly present and last over 2–3 weeks, but their time
course varying upon the model and species [32]. In the
present study Tibial and sural nerve transection-induced
alterations in the nociceptive threshold, are consistent
with the earlier reports [21,31]. Additionally TST also
led to functional deficit in experimental animals. In
addition to above behavioral alteration TST also resulted
in rise in nerve tissue TNF –α, TBARS and Nitrite levels
and fall in reduced glutathione level. The involvement
of TNF-α has been well recognized in peripheral as
well central sensitization in neuropathic pain [33]. The
up-regulation of TNF-α in peripheral nerve region is
followed by augment in the cytokine levels in the neurons
of dorsal root ganglia of the spinal cord [34]. Further, Data
from previous reports confirmed the role of oxidative
stress in development of neuropathic pain including TST
induced neuropathy [35,36]. Therefore inflammation &











Normal control 1.94 ± 0.25 2.87 ± 0.11 50.47 ± 3.21 26.35 ± 2.23 13.34 ± 1.54
Sham control 2.06 ± 0.34 3.07 ± 0.43 51.24 ± 3.05 28.23 ± 2.89 14.03 ±1.06
Vehicle in TST 2.13 ± 0.32 8.97 ± 0.41 27.56 ± 2.46 43.24 ± 2.56 66.14 ± 1.62
TST 2.44 ± 0.24 9.07 ±0.41a 28.14 ± 3.05a 44.04 ± 2.72a 67.11 ± 2.82a
PFE 300 mg/kg per se 2.11 ± 0.12 3.27 ± 0.12 50.22 ± 2.86 27.13 ± 1.87 12.44 ± 1.35
GABAPENTIN 100 mg/kg per se 2.17 ± 0.25 2.84 ± 0.49 50.66 ± 2.45 27.05 ± 1.43 12.57 ± 1.68
PFE 100 mg/kg + TST 2.67 ± 0.46 5.04 ± 0.53b 40.12 ± 2.55b 37.62 ± 2.54b 50.21 ± 2.51b
PFE 300 mg/kg + TST 2.21 ± 0.22 3.87 ± 0.38b 46.62 ± 2.33b 33.15 ± 2.39b 21.39 ±2.23b
BADGE + PFE 100 mg/kg + TST 2.49 ± 0.32 6.13 ± 0. 36c 33.61 ± 2.38c 38.18 ± 2.61c 57.62 ± 1.11c
BADGE + PFE 300 mg/kg + TST 2.16 ± 0.61 5.55 ± 0. 18d 38.12 ± 1.58d 35.16 ± 2.47d 38.01 ± 2.14d
BADGE + TST 2.43 ± 0.28 9.87 ± 0. 44a 54.67 ± 2.39a 46.86 ± 2.77a 68.41 ± 2.11a
L-NAME + TST 2.10 ± 0.53 6.95 ± 0. 14b 37.22 ± 3.04b 32.35 ± 2.23b 64.17 ± 2.22b
L-arginine + TST 2.58 ± 0.23 9.95 ± 0. 46a 25.28 ± 2.88a 48.61 ± 1.58a 66.31 ± 2.35a
L-NAME + PFE 100 mg/kg + TST 2.73 ± 0.18 5.01 ± 0.47b 39.17 ± 2.23b 35.96 ± 2.83b 51.89 ± 1.18b
L-NAME + PFE 300 mg/kg + TST 2.89 ± 0.29 3.75 ± 0. 23b 48.01 ± 1.06b 31.48 ± 2.98b 21.98 ± 2.21b
L-arginine + PFE 100 mg/kg + TST 2.93 ± 0.41 6.14 ± 0.11b 37.33 ± 2.81b 42.48 ± 2.14b 49.47 ± 2.36b
L-arginine + PFE 300 mg/kg + TST 2.34 ± 0.45 6.43 ± 0. 59e 36.83 ± 2.91e 35.36 ± 2.37e 22.08 ± 2.38e
GABAPENTIN 100 mg/kg + TST 2.09 ± 0.59 8.94 ± 0. 25 31.44 ± 2.33 30.15 ± 3.44b 62.16 ± 2.59
a = P < 0.05 vs. sham control group.
b = P < 0.05 vs. TST group.
c = P < 0.05 vs. PFE 100 + TST.
d = P < 0.05 vs. PFE 300 + TST.
e = P < 0.05 vs. L-NAME + PFE (300 mg/kg) + TST.
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pathic pain.
In our study, administrations of PFE (100 & 300 mg/kg
p. o.) for 24 days significantly attenuate TST-induced
behavioral alterations including cold, mechanical and
heat hyperalgesia; dynamic mechanical allodynia & cold
allodynia. PFE also attenuated the tibial functional index
(TFI) in significant manner. In addition, treatment of PFE
also prevent TST induced rise in nerve tissue TNF –α,
TBARS levels. Moreover, TST induced depletion of re-
duced glutathione was reversed by PFE treatment. Several
studies evidenced that PFE attenuate Alzheimer’s disease
[37]. PFE also shown to exert anti-inflammatory activity in
several in vitro studies [8,38]. Studies have also reported
significant anti oxidative effect of PFE [9]. Therefore, it
may be specified that the observed ameliorative effect
of PFE in TST induced neuropathic pain are probably
mediated through its anti inflammatory & antioxidant
actions.
Further, it has also been documented that PFE is an
activator of PPAR gamma [39]. The presence of PPAR γ
receptors in the dorsal horn of the spinal cord indicates
their possible involvement in a pain perception and a
transmission pathway [40,41]. PPAR γ activators have
been documented to attenuate the TST, L5 spinal nervetransection and partial sciatic nerve ligation induced
neuropathic pain [9,42]. In this study we observed that
pretreatment of BADGE (a PPAR γ antagonist) abolish
the protective effect of PFE on TST induced neuropathy.
Thereby indicate the involvement of PPAR γ mediated
action of PFE in TST induced neuropathy.
On the other hand TST resulted in increase in nitrite
level. These findings are in line with a report of injured
sciatic nerve of old rats [43]. Earlier reports demonstrated
that L5-6 spinal nerves ligation up-regulate the concentra-
tion of NOS in the corresponding spinal segments [44].
Augmentation of nitric oxide delayed the schwann cell dif-
ferentiation consequently slows down functional recovery
and axon regeneration after nerve Injury [45]. However,
it’s (all three type of NOS) exact role is not clear. In the
present study PFE pretreatment significantly attenuated
the increase nitric oxide level in TST induced neuropathic
pain. Chia-Jung Lee et al. also demonstrated inhibition
of NO production and iNOS expression in RAW 264.7
cells by four pomegranate fruit component (Punicalagin,
Punicalin, Strictinin A and Granatin B). Moreover, L-NAME
(nonselective NOS –inhibitor) and L- Arginine (NO -donor)
pretreatment significantly modified the protective effect of
PFE, indicating the role of NO pathway in its protective
effects. Inhibition of NO pathway by L-NAME significantly
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with L-arginine along with PFE significantly abolishes the
protective effect of PFE as compared to PFE alone. These
finding suggest the possible involvement of NO pathway in
protective effect of PFE.
The recent studies have reported that pioglitazone
(PPAR gamma agonist) protects dopaminergic neurons
against LPS insult at least via inhibiting iNOS expression
and NO generation (through PI3K pathway activation),
which is potentially mediated via inhibition of p38 MAPK
activity [46]. Thus it may be possible that these two sig-
naling pathways play a crucial role in attenuating effect of
PFE in TST induced neuropathic pain in an inter-
dependent manner.
Hence the results of the current study, give the impres-
sion that, TST-induced nociceptive alterations may be due
to the dysregulation of PPAR gamma receptor activity
along with increase in inflammation, oxidative stress and
nitric oxide production. Therefore, it may be proposed
that PFE mediated PPAR gamma agonistic activity, Nitric
oxide inhibition, anti-inflammatory activity and decrease
in the oxidative stress is responsible for its ameliorative
potential in TST-induced neuropathic pain.
Gabapentin is standard drug for neuropathic pain.
Therefore, gabapentin was used as positive standard to
compare protective effect of PFE in this study.Conclusion
Administration of PFE attenuates pain related pain behav-
iour in Tibial & Sural Nerve Transection injury model.
The attenuating effect of PFE in TST may be due to its
PPAR gamma agonistic activity, anti-inflammatory proper-
ties, nitric oxide inhibition and ability to decrease oxida-
tive stress. Nevertheless, further studies are warranted to
explore full potential & mechanism of action of PFE in
neuropathic pain.
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